Literature DB >> 19027282

Regression of copper-deficient heart hypertrophy: reduction in the size of hypertrophic cardiomyocytes.

Zhanxiang Zhou1, W Thomas Johnson, Y James Kang.   

Abstract

Dietary copper (Cu) deficiency causes cardiac hypertrophy and its transition to heart failure in a mouse model. Cu repletion results in rapid regression of cardiac hypertrophy and prevention of heart failure. The present study was undertaken to understand dynamic changes of cardiomyocytes in the hypertrophic heart during the regression. Dams of FVB mice were fed a Cu-deficient (CuD) diet (0.3 mg Cu/kg) starting on Day 3 post-delivery, and weanling pups were fed the same diet until Cu repletion (6.0 mg Cu/kg) in the diet at 31 days of age. Heart samples were obtained at the end of CuD feeding or at 3, 7, 14 or 28 days after Cu repletion. Cu deficiency resulted in increases in the size and reduction in the number of cardiomyocytes in the heart. Cu repletion led to regression in the size of hypertrophic cardiomyocytes and normalization of the total number of cardiomyocytes. Although a direct reduction in the cell size would be significantly responsible for the regression of heart hypertrophy, some hypertrophic cardiomyocytes upon Cu repletion reentered the cell cycle as determined by Ki-67 staining in the cardiomyocyte-specific alpha-sarcomeric actin-stained cells and underwent division as determined by a mitosis-specific marker, phospho-histone 3. Quantitative analysis indicated that the replication of hypertrophic cardiomyocytes made a contribution of about one-third to the total mitosis of the regenerated myocardium. This study suggests that a direct reduction in the size of some hypertrophic cardiomyocytes and a replication of other hypertrophic cardiomyocytes with reduced size make a significant contribution to the regression of CuD heart hypertrophy, leading to normalization of the size and the number of cardiomyocytes in the heart.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19027282      PMCID: PMC3458645          DOI: 10.1016/j.jnutbio.2008.06.007

Source DB:  PubMed          Journal:  J Nutr Biochem        ISSN: 0955-2863            Impact factor:   6.048


  27 in total

Review 1.  The Ki-67 protein: from the known and the unknown.

Authors:  T Scholzen; J Gerdes
Journal:  J Cell Physiol       Date:  2000-03       Impact factor: 6.384

Review 2.  Diastolic dysfunction in congestive heart failure.

Authors:  W Grossman
Journal:  N Engl J Med       Date:  1991-11-28       Impact factor: 91.245

3.  Regression of cellular hypertrophy after left ventricular assist device support.

Authors:  A Zafeiridis; V Jeevanandam; S R Houser; K B Margulies
Journal:  Circulation       Date:  1998-08-18       Impact factor: 29.690

Review 4.  Apoptosis in heart failure.

Authors:  H N Sabbah; V G Sharov
Journal:  Prog Cardiovasc Dis       Date:  1998 May-Jun       Impact factor: 8.194

Review 5.  Changes in beta-adrenoceptors and G-proteins during the transition from cardiac hypertrophy to heart failure.

Authors:  M Flesch; E Erdmann; M Böhm
Journal:  J Card Fail       Date:  1996-12       Impact factor: 5.712

Review 6.  Newer findings on a unified perspective of copper restriction and cardiomyopathy.

Authors:  D M Medeiros; R E Wildman
Journal:  Proc Soc Exp Biol Med       Date:  1997-09

7.  Trace elements in human myocardial infarction determined by neutron activation analysis.

Authors:  P O Wester
Journal:  Acta Med Scand       Date:  1965-12

8.  Comparative responses of rats to different copper intakes and modes of supplementation.

Authors:  L M Klevay; J T Saari
Journal:  Proc Soc Exp Biol Med       Date:  1993-06

9.  Congestive heart failure in copper-deficient mice.

Authors:  Laila Elsherif; Raymond V Ortines; Jack T Saari; Y James Kang
Journal:  Exp Biol Med (Maywood)       Date:  2003-07

10.  Copper reverses cardiomyocyte hypertrophy through vascular endothelial growth factor-mediated reduction in the cell size.

Authors:  Yang Zhou; Youchun Jiang; Y James Kang
Journal:  J Mol Cell Cardiol       Date:  2008-04-09       Impact factor: 5.000

View more
  7 in total

Review 1.  Human copper transporters: mechanism, role in human diseases and therapeutic potential.

Authors:  Arnab Gupta; Svetlana Lutsenko
Journal:  Future Med Chem       Date:  2009-09       Impact factor: 3.808

Review 2.  Analytical Methods for Imaging Metals in Biology: From Transition Metal Metabolism to Transition Metal Signaling.

Authors:  Cheri M Ackerman; Sumin Lee; Christopher J Chang
Journal:  Anal Chem       Date:  2016-12-15       Impact factor: 6.986

Review 3.  Regression of pathological cardiac hypertrophy: signaling pathways and therapeutic targets.

Authors:  Jianglong Hou; Y James Kang
Journal:  Pharmacol Ther       Date:  2012-06-29       Impact factor: 12.310

4.  The Effect of Multispecies Probiotic Supplementation on Iron Status in Rats.

Authors:  Katarzyna Skrypnik; Paweł Bogdański; Marcin Schmidt; Joanna Suliburska
Journal:  Biol Trace Elem Res       Date:  2019-02-12       Impact factor: 3.738

Review 5.  The Molecular Mechanisms of Defective Copper Metabolism in Diabetic Cardiomyopathy.

Authors:  Xiangning Cui; Yan Wang; Han Liu; Mengjun Shi; Jingwu Wang; Yifei Wang
Journal:  Oxid Med Cell Longev       Date:  2022-10-04       Impact factor: 7.310

6.  Copper deficiency may be a leading cause of ischaemic heart disease.

Authors:  James J DiNicolantonio; Dennis Mangan; James H O'Keefe
Journal:  Open Heart       Date:  2018-10-08

Review 7.  An Emerging Role of Defective Copper Metabolism in Heart Disease.

Authors:  Yun Liu; Ji Miao
Journal:  Nutrients       Date:  2022-02-07       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.